UBIVERTATUG
UNII ERA4BF5CUK

Substance Identification & Data

This profile provides standardized clinical and technical data for Ubivertatug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ERA4BF5CUK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3081662-54-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ERA4BF5CUK

CAS Registry Number

3081662-54-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

UBIVERTATUG

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

14190

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Ubivertatug

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ubivertatug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Ubivertatug

Common Names & Synonyms

Gamma1 heavy chain (1-450) [VH Musmus/Homsap (Mus musculus IGHV5-9*01 (88.8%) -(IGHD) -IGHJ4*01 (86.7%) V124>I (116)/Homo sapiens IGHV3-23*04 (87.8%) -(IGHD) -IGHJ4*01 (78.6%) L123>S (115), V124>I (116), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*01 (100%) G1m17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (217) (121-218), hinge 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)], (223-220')-disulfide with L-kappa light chain (1'-220') [V-KAPPA Musmus/Homsap (Mus musculus IGKV8-28*01 (83.2%) -IGKJ5*01 (91.7%) L126>I (112')/Homo sapiens IGKV2-28*01 (79.2%) -IGKJ2*01 (90.9%) Q120>A (106'), CDR-IMGT [12.3.9] (27'-38'.56'-58'.95'-103')) (1'-113') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (159'), V101 (197')) (114'-220')]; dimer (229-229'':232-232'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa

Immunoglobulin G1, anti-(human claudin CLDN18.2) (human-Mus musculus monoclonal ATG-022 γ1-chain), disulfide with human-Mus musculus monoclonal ATG-022 κ-chain, dimer

Immunoglobulin G1-kappa, anti-[Homo sapiens CLDN18 (claudin 18, claudin-18, surfactant associated protein J, SFTPJ) isoform 2)], monoclonal antibody

ubivertatug [INN]

External Clinical & Regulatory Resources

Previous UNIIER9WX3S7IR

Next UNIIERA6T22VER